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After first detections of carbapenemase-producing Enterobacteriaceae (CPE) in animals,
the European Union Reference Laboratory for Antimicrobial Resistance has provided
a protocol for the isolation of carbapenemase-producing Escherichia (E.) coli from
cecum content and meat. Up to now, only few isolates were recovered using this
procedure. In our experience, the choice of the selective agar is important for the
efficacy of the method. Currently, the use of the prevailing method fails to detect CPE
that exhibit a low resistance against carbapenems. Thus, this study aims to evaluate
the suitability of selective media with antibiotic supplements and commercial ChromID R©
CARBA agar for a reliable CPE detection. For comparative investigations, detection
of freeze-dried carbapenemase-resistant bacteria was studied on different batches
of the ChromID R© CARBA agar as well as on MacConkey agar supplemented with
1 mg/L cefotaxime and 0.125 mg/L meropenem (McC+CTX+MEM). The suitability
of the different media was assessed within a time of 25 weeks, starting at least
six weeks before expiration of the media. Carbapenem-resistant isolates exhibiting a
serine-based hydrolytic resistance mechanism (e.g., blaKPC genes) were consistently
detected over 25 weeks on the different media. In contrast, carbapenemase producers
with only slightly reduced susceptibility and exhibiting a zinc-catalyzed activity (e.g.,
blaVIM, blaNDM, and blaIMP) could only be cultivated on long-time expired ChromID R©
CARBA, but within the whole test period on McC+CTX+MEM. Thus, ChromID R© CARBA
agar appears to be not suitable for the detection of CPE with slightly increased minimum
inhibitory concentrations (MIC) against carbapenems, which have been detected in
German livestock and thus, are of main interest in the national monitoring programs.
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Our data are in concordance with the results of eleven state laboratories that had
participated in this study with their ChromID R© CARBA batches routinely used for the
German CPE monitoring. Based on the determined CPE detection rate, we recommend
the use of McC+CTX+MEM for monitoring purposes. This study indicates that the
use of ChromID R© CARBA agar might lead to an underestimation of the current CPE
occurrence in food and livestock samples.
Keywords: carbapenemase, isolation, media, specificity, sensitivity
INTRODUCTION
Carbapenems are important antimicrobial substances with
broad activity against almost all β-lactams. They are essential
to treat severe human infections with multidrug-resistant
Gram-negative bacteria. Due to their high impact in human
medicine, dissemination of carbapenem-resistant bacteria
should be avoided (Sharland et al., 2018; European Medicines
Agency [EMA], 2019). Actually, more than 2,000 variants
of carbapenemase resistance genes have been described that
were allocated to the β-lactamases of Ambler classes A, B,
and D (Codjoe and Donkor, 2017; Grundmann et al., 2017).
Klebsiella pneumoniae carbapenemases (KPC) and defined OXA
enzymes are common Ambler class A and D carbapenemases,
respectively, with a serine residue in their active sites (Codjoe
and Donkor, 2017). New Delhi metallo-β-lactamases (NDM)
and Verona integron-encoded metallo-β-lactamases (VIM)
are predominant Ambler class B enzymes. Their resistance
mechanism depends on the interaction of the carbapenems with
zinc ions in the active site of the enzymes (Codjoe and Donkor,
2017). Carbapenemase genes are often located on mobile genetic
elements (i.e., transposons/integrons, plasmids, phages), which
support horizontal transmission of the genes between different
bacteria (Carattoli, 2009; Miriagou et al., 2010; Tato et al., 2010).
The genes are often co-located with genes mediating resistance to
other antimicrobial classes. This leads to an important reduction
of therapeutic options in human medicine (Woodford et al.,
2014). In addition, various chromosomal mechanisms are also
involved in resistance development against carbapenems, i.e.,
changes in membrane permeability due to the loss of specific
outer membrane porins (Miriagou et al., 2010).
For a long time, carbapenemase-producing
Enterobacteriaceae (CPE) were almost exclusively associated
with human medicine. However, the number of reported isolates
from wildlife, companion animals, livestock, and food increases
worldwide (Köck et al., 2018). To get deeper insights into the
dynamics of occurring CPE, the European Union (EU) set up a
carbapenem-resistance monitoring for Escherichia coli isolates
from food products and livestock (Schrijver et al., 2018). Aside
from clinical settings, the carbapenemase enzymes OXA, VIM,
NDM, and KPC possess the highest impact in wildlife, pets, and
the food chain (Grundmann et al., 2017; Köck et al., 2018). In
Germany, France, Italy, Spain, and the Netherlands, reports have
been published about carbapenem-resistant Enterobacteriaceae
(CRE) in companion animals (i.e., dogs, cats, horses) (Stolle
et al., 2013; Schmiedel et al., 2014; Gonzalez-Torralba et al.,
2016; Melo et al., 2017; Vittecoq et al., 2017; Pulss et al., 2018),
seafood (i.e., shrimps, blue mussels, cockles) (Roschanski et al.,
2016; Ceccarelli et al., 2017), wild animals (i.e., yellow-legged
gulls, black kite) (Fischer et al., 2013b; Vergara et al., 2017;
Vittecoq et al., 2017), and food of livestock animals (i.e., beef,
chicken meat, pork) (Schwaiger et al., 2008; Leverstein-van Hall
et al., 2011; Poirel et al., 2012; Zurfluh et al., 2016; Ceccarelli
et al., 2017; Fischer et al., 2017; Pulss et al., 2017; Randall et al.,
2017; Roschanski et al., 2017, 2018). In 2011, VIM-1-producing
Enterobacteriaceae (Salmonella Infantis and E. coli) were found
in several chicken and pig farms in Germany (Borowiak et al.,
2017; Falgenhauer et al., 2017; Fischer et al., 2017; Irrgang
et al., 2017, 2019; Roschanski et al., 2018). The European Union
Reference Laboratory for Antimicrobial Resistance (EURL-AR)
together with national experts on antimicrobial resistances
developed a culture-dependent procedure for the isolation of
carbapenemase-producing E. coli from meat and cecum content
samples1. As no validated method for isolates from food exists,
this method is currently used in the annual monitoring on
carbapenemase-producing E. coli from livestock and food in
Germany and other European member states. In Germany,
we recognized on several occasions within the monitoring and
during additional studies that the method failed to detect CPE
that were identified in the same sample using a different method.
One example was an isolate in 2017, which was detected in
the monitoring on ESBL/AmpC β-lactamases but could not be
detected within the German CPE monitoring. It was a VIM-
1-producing E. coli from the cecum content of a fattening pig
at slaughter that exhibited minimum inhibitory concentrations
(MIC) ranging around the current cutoff values for the tested
carbapenems. These cutoff values are considerably lower than
the MIC of CPE of human clinical origin (European Food Safety
Authority [EFSA], and European Centre for Disease Prevention
and Control [ECDC],, 2017, 2019). Thus, there was the necessity
to improve the isolation method for CPE with low carbapenem
MIC values from food and livestock samples.
Due to the prevailing deficit in reliable detection of CPE
exhibiting low MIC values, this study aims to determine the
sensitivity of the selective cultivation after enrichment of the
samples for the laboratory routine in detecting CPE. Thus, the
suitability of different selective media for the recovery of CPE
was assessed. Beside the frequently used ChromID R© CARBA
agar (bioMérieux, Nürtingen, Germany) (Nordmann et al.,
2012; Girlich et al., 2013; Papadimitriou-Olivgeris et al., 2014),
1https://www.eurl-ar.eu/protocols.aspx
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which is also predominantly used by the German federal state
laboratories, we also determined the sensitivity of MacConkey
agar supplemented with cefotaxime and meropenem over a time
interval of 25 weeks.
MATERIALS AND EQUIPMENT
Bacterial Strains
Five carbapenem-resistant isolates were used for the evaluation
of the different selective media (Table 1). We chose three
CPE (E. coli: CP-3 and CP-9; Salmonella Corvallis: CP-5),
which had previously been recovered from German food and
livestock samples (Fischer et al., 2013b; Irrgang et al., 2017), one
carbapenemase-producing Vibrio parahaemolyticus (CP-8) from
seafood and one carbapenem-resistant K. pneumoniae isolate
from a pig slaughterhouse that lacks carbapenemase production
(CR-1). As references for quality assurance concerning the
selectivity of the media, the ESBL-producing E. coli isolate AR-1
(Wilkinson et al., 2012) and E. coli ATCC 25922 were used.
Further information on the bacterial isolates used in this
study is summarized in Table 1. Detailed information on the
MIC values of the isolates for 14 antimicrobials (ampicillin,
cefotaxime, ceftazidime, chloramphenicol, ciprofloxacin, colistin,
florfenicol, gentamicin, kanamycin, nalidixic acid, streptomycin,
sulfamethoxazole, tetracycline, and trimethoprim) is provided in
the Supplementary Table S1.
Media and Supplements
If not stated otherwise, all bacteria were cultivated in lysogeny
broth (LB) at 37◦C for 16–20 h under shaking conditions (120–
160 rpm). Solid media agars containing 0.8% (w/v) Bacto agar
(Oxoid, Dassel, Germany) were used. If necessary, antimicrobial
substances were supplemented to the media as indicated. All
media (listed in Table 2) of this study were stored at 4–6◦C in




The susceptibility to antimicrobials of the isolates was
determined by broth microdilution using defined antimicrobial
substances and concentrations from the harmonized EU
panel [plates EUVSEC and EUVSEC2; TREK Diagnostic
Systems (Thermo Fisher Scientific, Schwerte, Germany)].
Resistance testing was conducted according to the EN ISO20776-
1:2006 (European Food Safety Authority [EFSA], and European
Centre for Disease Prevention and Control [ECDC],, 2018), and
MIC values were interpreted based on EUCAST definitions2
using epidemiological cutoff values. The testing was repeated
three times (Supplementary Table S1). As quality control strain,
E. coli ATCC 25922, was used.
2www.eucast.org
Preparation of Freeze-Dried Bacteria
To ensure that equal amounts of bacterial cells were used
throughout the whole study, a single batch of freeze-dried
isolates was prepared using an Epsilon 2-10D LSC lyophilization
instrument (Christ, Osterode am Harz, Germany) with the
following procedure. Bacterial enrichments were prepared by
inoculating 2 mL LB broth, supplemented with 1 mg/L
cefotaxime (CTX), with a single colony of the carbapenem-
resistant or ESBL-producing isolates, while cultivation of E. coli
strain ATCC 25922 was conducted in LB without antimicrobials.
The inoculated broths were cultured for 16–20 h at 37 ± 2◦C
on a rotational shaker (180 rpm). Following incubation, 150 µL
of the respective cultures was transferred into 2 mL of fresh
LB for further incubation at 37 ± 2◦C until an optical density
(OD600 nm) between 0.5 and 0.6 was reached. Thereafter, the
culture was diluted to 1:10,000 (103 to 104 CFU/mL) and
centrifuged at 4,000 g for 10 min. The bacterial cell pellet was
resuspended in lyophilization medium [glutamic acid 10.0 g/L;
NaOH (8%) 30.0 mL/L; Bacto tryptone 25.0 g/L; sucrose 50.0 g/L;
thiourea (CH4N2S) 2.0 g/L] and was applied in aliquots of
1 mL to the borosilicate glasses. Lyophilization was conducted
according to the standardized and validated procedure of the
German Federal Institute for Risk Assessment (BfR) (freezing;
condenser cooling to −50◦C; vacuuming the drying chamber;
main drying and post-drying). After lyophilization, the bacterial
concentrations (CFU/mL) of the freeze-dried bacteria were
determined under selective and non-selective conditions. The
bacterial concentration after resuspension, plating on LB agar
without any supplement and incubation overnight at 37◦C
accounted between 7.5 and 45× 103 CFU/mL.
Enumeration of Bacteria on Different
Media
To evaluate the performance of different agar types and the
impact of increasing storage time of ChromID R© CARBA plates,
bacterial growth on different media was determined weekly over
a period of 25 weeks as described below. Therefore, the respective
lyophilisates of the bacteria were resuspended in 1 mL double-
distilled water and incubated for 30–60 min at room temperature
for adaption of the bacteria. To exclude potential effects of the
commercial agar of the growth performance of the bacteria,
five different ChromID R© CARBA batches were tested. Aliquots
(50 µL) of the lyophilisate suspensions were plated on ChromID R©
CARBA plates. For comparative analysis of the commercial
agar to other media, the same lyophilisate suspensions were
also applied to LB agar and to MacConkey agar supplemented
with 1 mg/L CTX and 0.125 mg/L meropenem (MEM)
(McC+CTX+MEM). Both LB agar and McC+CTX+MEM were
produced in-house at the BfR. After an incubation period of 16–
18 h at 37 ± 2◦C, the bacterial concentration (CFU/mL) was
determined. For comparability, the storage time the bacterial
growth on the five ChromID R© CARBA batches was calculated
according to the expiry date.
Freeze-dried bacteria were also provided to 11 participating
federal state laboratories for comparative investigation. The
laboratories of Baden-Württemberg (Fellbach, Karlsruhe),
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Bavaria (Oberschleißheim), Hesse (Gießen), Lower Saxony
(Cuxhaven, Oldenburg), North Rhine-Westphalia (Arnsberg,
Detmold, Krefeld), Saxony (Chemnitz), and Saxony-Anhalt
(Stendal) conducted growth investigation according to the
specifications of the BfR. Overall, the selectivity of the ChromID R©
CARBA agar was tested on seven different batches. In contrast to
the long-term procedure of the BfR, the federal state laboratories
investigated the growth performance of the different isolates on
different selective media at three defined time points: (i) at the
expiry date, (ii) 2 weeks before, and (iii) 5 weeks after the expiry
date. The systematic procedure of all steps is shown in Figure 1.
RESULTS
Commercial selective medium is not suitable for
routine monitoring purposes on isolates from
livestock and food that exhibit low carbapenem
MIC values.
Therefore, the commercial ChromID R© CARBA agar was
tested out of date because of previous observations and
experiences. Freeze-dried bacteria, which were produced
within this study, showed growth between 5 × 102 CFU/mL
and 4.5 × 104 CFU/mL (Figure 2). Over the 25-week
period, the bacterial titer of the isolates did not change
significantly under non-selective conditions (LB). However,
we observed a slight decrease in the bacterial titer for
the isolates AR-1, CR-1, and CP-8 over the first time
points of enumeration (Figure 2). After 25 weeks, all
isolates were still reliably detectable under non-selective
conditions (Figure 2).
The results of the comparative analysis are summarized in
Supplementary Table S2. Results of comparative testing of
the different federal state laboratories were very similar. They
TABLE 1 | Strains and species used in this study with their resistance determinants (threefold determined MIC values, variations are indicated with a “/” between
the values).











E. coli DSMZ None − ≤0.015 0.25 ≤0.03 DSMZ
AR-1 E. coli Bovine cecum None − 0.25 0.5 0.6 This work
CP-3 E. coli Colon content
of a slaughter
pig




Wild bird blaNDM−1 + >2 4 8 Fischer et al.,
2013b
CP-8 V. parahaemolyticus Seafood blaNDM−1 + 0.25 1/2/4 0.25 This work
CP-9 E. coli Human blaKPC−2 + >2 4 8 This work
CR-1 K. pneumoniae Porcine cecum None − 2 0.5/1 0.5 This work
ERP, ertapenem; IMI, imipenem; MEM, meropenem. DSMZ, German collection of microorganisms and cell cultures. Moreover CP, carbapenemase-producing; CR,
carbapenem-resistant; and AR, antibiotic resistant.
TABLE 2 | List of media, reagents, materials, and equipment.
Material Produced by Further information Country
Lysogeny broth In-house Yeast extract 5 g/L; peptone from casein 10 g/L; NaCl
10 g/L
Lysogeny agar In-house Yeast extract 5 g/L; peptone from casein 10 g/L; NaCl
10 g/L; agar 12 g/L
Bacto agar Oxoid Dassel, Germany
Lyophilization medium In-house Glutamic acid 10.0 g/L; NaOH (8%) 30.0 mL/L; Bacto
tryptone 25.0 g/L; sucrose 50.0 g/L; thiourea (CH4N2S)
2.0 g/L
MacConkey agar In-house Peptone from casein 17 g/L; peptone from meat 3 g/L;
NaCl 5 g/L; lactose 10 g/L; bile salt mixture 1.5 g/L, neutral
red 0.03 g/L; crystal violet 0.001 g/L, agar 13.5 g/L
ChromID R© CARBA bioMérieux Nürtingen, Germany
Cefotaxime Sigma-Aldrich Taufkirchen, Germany
Meropenem Sigma-Aldrich Taufkirchen, Germany
Plates EUVSEC and EUVSEC2 Thermo Fisher Scientific Schwerte, Germany
Epsilon 2-10D LSC lyophilization
instrument
Christ Osterode am Harz, Germany
Sensititre AIMTM Automated Inoculation
Delivery System
TREK Diagnostic East Grinstead, United Kingdom
SensititreTM SWINTM Software System
3.3
Thermo Fisher Scientific Schwerte, Germany
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FIGURE 1 | Flow diagram of the systematic procedure.
FIGURE 2 | The growth of all lyophilisates on non-selective LB agar over the entire test period of 25 weeks. The x-axis (abscissa) shows the time in weeks, and the
y-axis (ordinate) shows CFU/mL.
indicated that only one isolate (CP-9) could be detected on the
used agar batches at all three time points. This respective isolate,
a human E. coli which carried the gene blaKPC−2, exhibited
a high MIC values against the tested carbapenems (Table 1).
None of the other isolates showed bacterial growth at the
selected time points.
To investigate the suitability of the ChromID R© CARBA agar
for the detection of CPE exhibiting low carbapenem MIC
values, the growth ability of the aforementioned isolates was
investigated at the NRL-AR over a time period of 25 weeks
using five different batches of the agar. The diagrams 2A–2E
show that at the beginning of the test, bacterial growth could
only be detected for isolate CP-9, exhibiting high MIC values
for the carbapenems ertapenem, imipenem, and meropenem
(Table 1 and Supplementary Table S1). Slight bacterial growth
could be detected for the isolates CP-3, CP-5, and CP-8
2 weeks before expiry date (week 7) (Figures 3A–C). This
detection increased over time and also after the expiry date. The
carbapenemase-producing isolate CP-9 showed a highly reliable
average growth rate between 5.0 × 103 and 2.5 × 104 CFU/mL
at all points of investigations over the 25 weeks (Figure 3D).
At the end of the trial, four carbapenem-resistant isolates
(CP-3; CP-5; CP-8; and CR-1) showed increased growth rates
(average: CP-3 with blaVIM−1: 4 to 32 CFU/mL; CP-5 with
blaNDM−1: 4 to 368 CFU/mL; and CP-8 with blaVIM−1: 4 to
24 CFU/mL). The CR-1 isolate that exhibits no carbapenemase-
production showed growth rates between 20 and 3920 CFU/mL
and was first detected 1 week before the expiry date of the
media (Figure 3E). The quality control isolate AR-1 (Table 1
and Supplementary Table S1) and the control strain ATCC
25922 did not grow on ChromID R© CARBA plates during the
investigated period.
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FIGURE 3 | The x-axis shows the time in weeks where “9” the expiry date is. The y-axis shows CFU/mL. (A) Growth of CP-3 on five tested batches of ChromID R©
CARBA agar. Moreover, the average of all batches is shown. (B) Growth of CP-5 on five tested batches of ChromID R© CARBA agar. Moreover, the average of all
batches is shown. (C) Growth of CP-8 on five tested batches of ChromID R© CARBA agar. Moreover, the average of all batches is shown. (D) Growth of CP-9 on five
tested batches of ChromID R© CARBA agar. Moreover, the average of all batches is shown. (E) Growth of CR-1 on five tested batches of ChromID R© CARBA agar.
Moreover, the average of all batches is shown. (F) Growth of the both control strains NK and AR-1 on five tested batches of ChromID R© CARBA agar.
Supplementing 1 mg/L CTX and 0.125 mg/L MEM to the agar
basis of the MacConkey medium can overcome growth inhibition
during cultivation of low-carbapenem MIC-exhibiting isolates.
The growth performance of the abovementioned isolates
was also determined on McC+CTX+MEM agar. In contrast
to ChromID R© CARBA agar, all carbapenem-resistant isolates
were reliably detected at all time points within the 25-
week period of investigation (Table 3). The growth of the
CP-9 isolate was similar on McC+CTX+MEM, ChromID R©
CARBA agar as well as under non-selective conditions (LB
agar) ranging between 2.4 × 103 and 3.3 × 104 CFU/mL.
With the focus on the isolates (AR-1 and NK) used as
quality controls, McC+CTX+MEM has a reliable specificity
of up to 22 weeks, as within this period no bacterial growth
was observed.
DISCUSSION
Previous experiments in our laboratory showed that the
ChromID R© CARBA agar becomes more sensitive with increasing
storage time. Based on the observations and experiences
within the laboratory routine (International Organization
for Standardization, 2006; Fischer et al., 2013a,b, 2017;
Irrgang et al., 2017, 2019), detection of carbapenemase-
producing bacteria is challenging using the EURL-AR method
in combination with ChromID R© CARBA agar. We assume
that the concentration of different ingredients and thus the
selectivity will decrease with time or after the expiry date.
This justifies the choice of times to determine a possible
decrease in antimicrobial concentration after the shelf life of
ChromID R© CARBA agar.
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TABLE 3 | Growth of the seven lyophilisates tested once a week over 25 weeks on MacConkey agar supplemented with 0.125 mg/L meropenem and 1 mg/L
cefotaxime.
Week 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
AR-1 − − − − − − − − − − − − − − − − − − − − − − + + +
CP-3 + + + + + + + + + + + + + ++ + ++ ++ ++ ++ + + ++ ++ ++ ++
CP-5 + + + + + + + + + + + + + + + + + + + + + + + + +
CP-8 + − − + + + + + + + + − + + + + + + + + − + + + +
CP-9 +++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
CR-1 ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
NK − − − − − − − − − − − − − − − − − − − − − − − − −
“−” means no growth; “+” means 1–100 cfu/mL; “++” means 100–1000 cfu/mL; “+++” means ≥1000 cfu/mL.
Within this study, we observed strong differences in the
growth performance of the used carbapenem-resistant isolates
on the selective media. These different growth performances
exceed the observed slight decrease of AR-1, CR-1, and CP-
8 during the first time points of enumeration, which seems
to represent a natural adaption of the specific isolates to the
prevailing cultivation conditions (Figure 2).
As previously reported (Fischer et al., 2012; Köck et al.,
2018), carbapenem-resistant isolates from food products or
livestock exhibit significantly lower MIC values for the respective
carbapenems than clinical isolates. There may be different
reasons for this observation. It could be due to molecular
conditions, such as a variable number of gene copies, a different
expression of the genes, or a different genetic localization
(plasmid versus chromosomal DNA). It could also be due to
the different antimicrobial selection pressures to which the
strains are exposed. As carbapenems are not licensed for use in
food animals, previous exposure of the strains with a livestock
origin is unlikely. The chosen isolates for the evaluation of the
selective cultivation step of the detection procedure represent
different bacterial genera and carbapenem resistance genes as
well as resistance mechanisms (Viau et al., 2012; Köck et al.,
2018). The E. coli isolate CP-9 carries a blaKPC−2 gene and
exhibited high MIC values against all tested carbapenems.
CP-9 represents typical MIC values for carbapenems of human
isolates (Supplementary Table S1). Other target isolates, except
CP-5 (the NDM-producing Salmonella) exhibited carbapenem
resistance but showed only MICs ranging around the current
cutoff values (Supplementary Table S1). As the used isolates
exhibited very low MIC values, we suppose that the remaining
concentration of the supplemented antimicrobials is still high
enough to prevent a growth of these isolates.
The KPC enzymes belong to Amber class A carbapenemases
and use a serine-based hydrolytic mechanism to inactivate
carbapenems. In contrast, the VIM-1 and NDM-1 enzymes
belong to Ambler class B carbapenemases and convey the
resistances by a zinc-catalyzing active site (Codjoe and Donkor,
2017). Viau et al. (2016) reported that most of their ten
tested media performed reasonably well with different screening
methods for the detection of class A enzymes. Performance with
class B and D enzymes was more variable. However, Viau and co-
workers used up to 180 different CRE originating from human
clinical sources. They determined a good performance of the
ChromID R© CARBA medium if tested with rectal/perirectal swabs
(Jeon et al., 2015). The differences between CPE from human
samples and CPE from non-clinical animal samples have not
been investigated systematically so far as the number of available
non-clinical animal isolates is still limited. As the ingredients
of the ChromID R© CARBA agar are unknown and have not
been provided by the manufacturers on request, it is difficult to
assess the selective additives of the medium and to expect their
influence on the cultivation of CPE with low MIC. It might be
that an additive supports the serine-based hydrolytic resistance
mechanism in a better way than the zinc-based mechanism.
Within our study, CP-9 was the only isolate that was
consistently detected in all participating laboratories and with all
selective media. The determined amount of the adjusted, freeze-
dried bacteria ranged between 5 × 102 and 4.5 × 104 CFU/mL
between the laboratories. The other carbapenem-resistant isolates
(CP-3; CP-5; CP-8; and CR-1) showed no detectable growth
on the ChromID R© CARBA plates within the different federal
state laboratories up to 5 weeks after expiration date of the
plates (Supplementary Table S2). At this time point, the
agar will not be used by accredited laboratories as the agar
will be handled as expired according to the recommendations
of the manufacturers. However, each of these isolates was
reliably detected on McC+CTX+MEM (Table 3). The quality
control isolate AR-1, a CTX-M-1-producing E. coli with a
low phenotypical resistance against ertapenem (Table 1 and
Supplementary Table S1), and the quality control strain ATCC
25922 did not grow on ChromID R© CARBA plates at any time
(Figure 3F). As they grew at the last three time points on
McC+CTX+MEM, it can be assumed that the specificity of the
plates did not decrease considerably within a period of 20 weeks
after production (Table 3). In contrast, the number of CFU of
the isolates CP-3; CP-5; CP-8; and CR-1 increased at the end of
the investigated time interval. This indicates that the sensitivity
of the commercial agar increased over time.
In contrast to our study, other groups found that ChromID R©
CARBA agar was one of the most sensitive and specific
chromogenic medium for the detection of CPE (Vrioni et al.,
2012; Papadimitriou-Olivgeris et al., 2014; Simner et al., 2015;
Viau et al., 2016). However, in these studies, the MIC values of
the CPE are in general much higher than the MIC values of
the isolates tested here. In comparison, Vrioni et al. (2012) used
clinical isolates with very high MIC values of up to over 32 mg/L
to MEM, but they also used some strains with MIC values below
the resistance breakpoint. The detection of the isolates with these
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high MIC values might correlate much more with the detection
of CP-9 and is not comparable with the detection of isolates
exhibiting low MICs (CP-3, CP-8, and CR-1).
Limited detection of CPE might be also attributable to a
loss of the resistance-harboring plasmids during lyophilization
(Wagman and Weneck, 1963; Berman et al., 1968; Wein et al.,
2019). We can exclude this as an important factor in our study
because we observed similar bacterial titers on selective and
non-selective in-house media (data not shown). We had also
confirmed the presence of the plasmid in some representative
colonies from selective and non-selective media.
Overall, we have detected more CFU/mL by using the
conventional MacConkey agar supplemented with antibiotics
over the entire period for almost all isolates of this study. Due
to the lacking resistance against carbapenems, the quality control
strain ATCC 25922 could not be detected on McC+CTX+MEM,
indicating the appropriate specificity of the medium. Some
spontaneous growth of the E. coli isolate AR_1 was observed
22, 23, and 24 weeks after agar production, indicating that the
prepared agar worked with a high specificity for up to 22 weeks.
In contrast to this observation, the AR_1 isolate could not be
detected on the ChromID R© CARBA agar. The concentration of
meropenem (0.125 mg/L) in the supplemented agar is lower than
the current ECOFFs (0.25 mg/L) (Giske et al., 2013). Based on this
concentration, CPE with low MIC values are also able to grow
successfully and will further be detected within the monitoring
programs. Viau et al. (2012) reported about “silent” dissemination
of K. pneumoniae, because some isolates were not identified
as carbapenem-resistant based on their MIC, even though they
carried a carbapenemase gene and showed slightly increased MIC
values against ertapenem and meropenem (Fischer et al., 2012).
Berthoin et al. (2010) reported that the stability of meropenem
in solutions depends on time, temperature, and concentration
(Berthoin et al., 2010). These observations were supported by
Keel et al. (2011). A potential effect of light on the stability of
meropenem can be excluded, as the agar plates were only exposed
to light during plating and visual inspection. Therefore, it was
assumed that the stability of meropenem in the media might
be limited. In our study, the McC+CTX+MEM agar was stably
usable for up to 22 weeks without a loss of specificity when stored
at 4 ± 2◦C. The supplementation with cefotaxime supported the
selective effect, but for OXA-48 producers this antibiotic should
be omitted. Changes in sensitivity and specificity of MacConkey
agar supplemented with meropenem only over time were not
tested in our study. Adler et al. (2011) used MacConkey agar
supplemented with imipenem at 1 mg/mL (McC+IMI) and
compared this medium with a commercial selective medium
(CHROMagar KPC, CHROMagar Company, Paris, France).
They described a similar performance of both media during
clinical evaluation. Moreover, they argued with the lower costs
of McC+IMI to prefer it for detection of CRE in their study
(Adler et al., 2011). We decided to use meropenem as supplement
because it is more stable than imipenem (Zhanel et al., 2007).
Based on our data, we recommend using McC+CTX+MEM for
selective cultivation of carbapenem-resistant isolates from food
products and livestock samples.
Another important difference between the different agars
is that the ingredients of the in-house prepared agar are
known. In McC+CTX+MEM agar, no further substances
were supplemented for inhibition of accompanying bacteria.
It is possible that the commercial selective medium comprises
unspecified substances (e.g., zinc that is used to inhibit non-
carbapenemase-producing bacteria), which may also suppress the
growth of some CPE, e.g., with a low MIC. Although less selective
substances are used, no increased difficulties were found with the
accompanying flora in other experiments so far.
A limitation of this study is that only one batch of
McC+CTX+MEM plates was used throughout the experiment.
This was due to its function as a control medium, and it was not
the primary aim to compare both media.
CONCLUSION
The results of our study indicate that the ChromID R© CARBA agar
is not suitable for the cultural detection of CPE with low MIC to
carbapenems, while clinical isolates with higher MIC values can
be detected reliably. Overall, the use of the ChromID R© CARBA
agar in monitoring programs may lead to an underestimation
of the CPE occurrence in livestock and food as the method
lacks sensitivity.
We further provide data, that MacConkey agar with 1 mg/L
cefotaxime and 0.125 mg/L meropenem provides a better
sensitivity for the detection of such isolates and may be more
suitable for the carbapenemase monitoring in livestock and food.
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